Daily Health Headlines

Too Few U.S. Hispanics Have Cholesterol Under Control

👤by Robert Preidt 0 comments 🕔Monday, November 9th, 2015

MONDAY, Nov. 9, 2015 (HealthDay News) -- Undertreatment of high cholesterol is a major problem among Hispanics in the United States, a new study finds.

The research, to be presented Monday at the annual meeting of the American Heart Association in Orlando, Fla., found that only one-third to one-half of Hispanics who could benefit from cholesterol-lowering statin drugs were taking them.

One heart expert wasn't surprised by the finding.

"The result of this study is another clear demonstration of the extent of how disparities in health care access affect Hispanic patients," said Dr. Johanna Paola Contreras, an assistant professor of medicine and cardiology at The Mount Sinai Hospital in New York City.

Researchers assessed the need for treatment of high cholesterol among more than 16,400 Hispanic adults, and found that only about 10 percent were taking statins.

That's just half of the 20 percent who were deemed suitable for statin therapy, based on recommendations from the National Cholesterol Education Program Adult Treatment Panel. If the American College of Cardiology/American Heart Association's treatment guidelines were used as a yardstick, 32 percent would be deemed to gain a benefit from the medications, the researchers said.

The percentage of Hispanic adults eligible for statin therapy rose with age and was higher among males than females, said the team led by Dr. Waqas Qureshi, of Wake Forest University in Winston-Salem, N.C.

According to Contreras, "even more worrisome is that only about half of Hispanic patients know that they have high cholesterol; only a third are told that they need treatment."

Dr. Maria Pena, an endocrinologist at Lenox Hill Hospital in New York City, said that the heart health of Hispanic Americans has actually declined over the past few decades, alongside rising rates of obesity and diabetes.

"Therefore, it is imperative that this patient population be treated with both lifestyle modification counseling and drug therapy when necessary," Pena said. She added that statin drugs, in particular, are widely available and relatively cheap since many have gone generic in recent years.

According to Pena, some Hispanic patients may have a cultural bias against prescription statins, and that could be a key factor in curbing use of the drugs.

"It appears to me from my interactions with this patient population that there may be indeed a stigma against statins and an erroneous belief that certain home remedies, without the appropriate changes in diet and physical activity, can cure high cholesterol," she said. "It is our duty as clinicians to dispel these theories."

Findings presented at medical meetings are typically considered preliminary until published in a peer-reviewed journal.

-- Robert Preidt

Article Credits / Source

Robert Preidt / HealthDay

Robert Preidt wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCES: Johanna Paola Contreras, M.D., assistant professor of medicine, cardiology, heart failure and cardiac transplant, The Mount Sinai Hospital, New York City; Maria E. Pena, M.D., endocrinologist and director, Center for Weight Management, Lenox Hill Hospital, New York City; American Heart Association, news release, Nov. 9, 2015

View More Articles From Robert Preidt 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Cholesterol Articles

Lipitor (atorvastatin)

Lipitor (atorvastatin)0

home / cholesterol center / cholesterol a-z list / atorvastatin index / lipitor (atorvastatin) drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his ...

gemfibrozil, Lopid

gemfibrozil, Lopid0

home / cholesterol center / cholesterol a-z list / gemfibrozil index / gemfibrozil, lopid drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his Doctorate ...

fenofibrate (Antara, Fenoglide, Fibricor, Lipofen, Lofibra, Tricor, Triglide,  Trilipix)

fenofibrate (Antara, Fenoglide, Fibricor, Lipofen, Lofibra, Tricor, Triglide, Trilipix)0

home / cholesterol center / cholesterol a-z list / fenofibrate-oral index / fenofibrate (antara, fenoglide, fibricor, lipofen, lofibra, tricor, triglide, trilipix) drug monograph Pharmacy Author: ...

Are There Alternatives to Statins?

Are There Alternatives to Statins?0

TUESDAY, Sept. 27, 2016 (HealthDay News) -- Statins are the go-to therapy for lowering "bad" LDL cholesterol, but other treatments also can effectively reduce risk of future heart problems, a new evidence review reports. These alternative ...

Repatha (evolocumab)

Repatha (evolocumab)0

home / cholesterol center / cholesterol a-z list / evolocumab index / repatha (evolocumab) drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his Doctorate ...

View More Cholesterol Articles


Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!